Kenvue reported second quarter 2026 net sales of $3.96 billion, up 3.0% year-over-year, and adjusted diluted EPS of $0.31, a 7% increase. The results narrowly missed analyst expectations for both revenue and earnings. The company posted its third consecutive quarter of organic sales growth, which rose 1.6%, driven by a 0.9% increase in price/mix and a 0.7% increase in volume.
Key Highlights
- Net sales grew 3.0% to $3.96 billion, while organic sales increased 1.6%, marking the third straight quarter of growth.
- Skin Health and Beauty segment sales, a key investor focus, grew 5.1% to $1.11 billion, with organic sales up 3.7%.
- Adjusted diluted EPS rose 7% year-over-year to $0.31, slightly below the analyst consensus of $0.32.
- The company will not provide forward-looking guidance due to the pending acquisition by Kimberly-Clark, which is expected to close in the fourth quarter of 2026.